What Spyro How To is
Peptide dosing information online is unreliable: supplier pages list ranges with no sources, forums contradict each other, and trial data is buried in long PDFs. Spyro How To addresses that with a single, consistent reference where every dosing figure, reconstitution calculation, and safety note can be traced to a published source or is clearly labeled as community-derived.
It is openly the educational counterpart to the Spyro Peptides catalog: the protocols here cover the compounds Spyro supplies, so the dosing math matches the exact vial sizes you would actually be working with.
The standard protocol format
Every protocol page follows the same structure, so the same information always lives in the same place:
Quick-reference card
Class, formats, half-life/cadence, vial size, regulatory status at a glance.
Two dosing protocols
Injection and nasal spray documented separately, each with its own bands and schedule.
Reconstitution math
Concentration, draw volume, syringe units, and per-spray dose worked out per vial size.
Mechanism & evidence
Plain-English mechanism plus the clinical/preclinical evidence context.
Safety & regulatory
Side effects, who should avoid, monitoring, and current regulatory status.
FAQ & references
Answered questions and a numbered source list.
How evidence is graded
Not all evidence is equal. Each dosing figure is labeled by where it comes from, and community-derived ranges are never presented as clinical fact.
| Tier | Source | How it's used |
|---|---|---|
| 1 — Clinical trial | Published Phase 2/3 results, major journals | Primary source for clinically studied compounds (e.g., Tesamorelin, Retatrutide) |
| 2 — Systematic review | Meta-analyses, peer-reviewed reviews | Context across multiple studies |
| 3 — Regulatory / manufacturer | Regulatory filings, labels, pipeline data | Regulatory status and mechanism |
| 4 — Community protocol | Practitioner reports, established conventions | Only where trial data doesn't exist (e.g., BPC-157, TB-500) — always labeled |
Reconstitution methodology
Every reconstitution table is built from three inputs: the vial content, the bacteriostatic (BAC) water volume, and the resulting concentration. From there the draw volume and syringe units follow directly:
Draw volume (mL) = target dose (mcg) ÷ concentration (mcg/mL)
Syringe units (U-100) = draw volume (mL) × 100
Each table shows the math so it can be checked independently. Use the reconstitution calculator for any custom vial size or water volume.
The injection vs nasal-spray model
Each compound is offered as both a vial (subcutaneous injection) and a pre-mixed nasal spray, documented as separate protocols rather than merged. The spray ships ready to use; each protocol page lists the delivered dose per spray and the number of sprays per dose.
Where a route's absorption differs materially — most notably NAD+, where nasal uptake is lower than injection — the spray dose is adjusted and explained on the page rather than presented as a one-to-one swap.
What this site does not do
- It does not provide medical advice or recommend that anyone use, buy, or administer any compound.
- It does not claim compounds are safe or effective; it reports what the research shows, with sources.
- It does not run clinical trials or laboratory testing itself.
- The compounds covered are research materials, not approved medical treatments.
The compounds discussed are research materials and are not approved drugs. Consult a qualified healthcare provider before considering any compound.
Contact & corrections
Accuracy is the foundation of this reference. If you find an error in any dosing table, reconstitution figure, or citation, let us know and we will review and update the page. Each page carries a "Last reviewed" date and is updated when new research data publishes.